Skip to content
Emerging Indications and Techniques in MSK Ablation
Percutaneous Treatment of Bone Tumors – Case review
Percutaneous Thermal Ablation of Vertebral Metastasis
Sexual Differences in the Experience of Acute Post Procedural Pain after Thermal LIver Ablations; a Retrospective Study
Irreversible Electroporation in Hepatocellular Carcinomas Adjacent to Critical Anatomical Structures, a Single Centre Experience
Single Center Experience with Irreversible Electroporation for Locally Advanced Pancreatic Cancer
The Novel Image Guided Percutaneous Management of Inoperable Cancer of the Head of Pancreas – Technique and Results
Histotripsy Through Gas-Filled Colon and Small Bowel in an Ex Vivo Swine Model
Current role of systemic therapy in HCC
Role of genomics, molecular biomarkers and AI in HCC therapy
Revisiting the indications for Surgery vs Ablation
Time to Transplant – An important factor in selection of liver directed therapy
Navigating locoregional treatment options in HCC
Ablation with a curative intent in HCC
Impact of c-TACE on the management of HCC
Advances in DEB-TACE technology and clinical outcomes
Y90 in locally-advanced disease with PVT
3rd Annual James G. Caridi Lecture
Current systemic treatments – Chemotherapy, Immunotherapy & Target Agents
Locoregional treatments in Cholangiocarcinoma
How to incorporate molecular testing in therapy for localized disease
Percutaneous ablation strategies in Cholangiocarcinoma
Aiming for Better Outcomes: Comparing and Combining Systemic & Locoregional Therapies
Urology and IR working together – the NIH Experience
Focal therapy options in Prostate Cancer
Post navigation
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok 
